Spain’s renowned centre of excellence recognises importance of verifying radiosurgery plans ahead of patient treatment
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
Through the new agreements, Cristal Therapeutics and McSAF will gain access to Lonza’s integrated bioconjugates offering and will be able to leverage Lonza’s expertise in developing and manufacturing bioconjugates
The PharmaEssentia Innovation Research Center (PIRC) will advance the company’s diverse pipeline and research footprint in the U.S., driving job creation
If approved, the vaccine could help simplify the meningococcal vaccination schedule and provide the broadest serogroup coverage of any meningococcal vaccine
35 million mosquito nets supplied to countries in sub-Saharan Africa through partners
Antibody levels remained above baseline six months after completion of a three-dose (Month 0-2-6) or a two-dose (Month 0-6) vaccination schedule
It allows users to generate cell lines suitable for clinical development without their own starter cells, vectors or prior experience in the field.
Pfizer plans to submit an sBLA by the end of this year, subject to discussions with U.S. FDA
Capnomed successfully introduced the medical device Capnopen, the gold standard of laparoscopic nebulizers.
Subscribe To Our Newsletter & Stay Updated
